These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 24386447)

  • 1. Are we heeding the warning signs? Examining providers' overrides of computerized drug-drug interaction alerts in primary care.
    Slight SP; Seger DL; Nanji KC; Cho I; Maniam N; Dykes PC; Bates DW
    PLoS One; 2013; 8(12):e85071. PubMed ID: 24386447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-priority drug-drug interaction clinical decision support overrides in a newly implemented commercial computerized provider order-entry system: Override appropriateness and adverse drug events.
    Edrees H; Amato MG; Wong A; Seger DL; Bates DW
    J Am Med Inform Assoc; 2020 Jun; 27(6):893-900. PubMed ID: 32337561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overrides of medication-related clinical decision support alerts in outpatients.
    Nanji KC; Slight SP; Seger DL; Cho I; Fiskio JM; Redden LM; Volk LA; Bates DW
    J Am Med Inform Assoc; 2014; 21(3):487-91. PubMed ID: 24166725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicians' responses to computerized drug-drug interaction alerts for outpatients.
    Yeh ML; Chang YJ; Wang PY; Li YC; Hsu CY
    Comput Methods Programs Biomed; 2013 Jul; 111(1):17-25. PubMed ID: 23608682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medication-related clinical decision support alert overrides in inpatients.
    Nanji KC; Seger DL; Slight SP; Amato MG; Beeler PE; Her QL; Dalleur O; Eguale T; Wong A; Silvers ER; Swerdloff M; Hussain ST; Maniam N; Fiskio JM; Dykes PC; Bates DW
    J Am Med Inform Assoc; 2018 May; 25(5):476-481. PubMed ID: 29092059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overall performance of a drug-drug interaction clinical decision support system: quantitative evaluation and end-user survey.
    Van De Sijpe G; Quintens C; Walgraeve K; Van Laer E; Penny J; De Vlieger G; Schrijvers R; De Munter P; Foulon V; Casteels M; Van der Linden L; Spriet I
    BMC Med Inform Decis Mak; 2022 Feb; 22(1):48. PubMed ID: 35193547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of drug-drug interaction alert rules in a pediatric hospital's electronic health record system using a visual analytics dashboard.
    Simpao AF; Ahumada LM; Desai BR; Bonafide CP; Gálvez JA; Rehman MA; Jawad AF; Palma KL; Shelov ED
    J Am Med Inform Assoc; 2015 Mar; 22(2):361-9. PubMed ID: 25318641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Investigation of Drug-Drug Interaction Alert Overrides at a Pediatric Hospital.
    Humphrey K; Jorina M; Harper M; Dodson B; Kim SY; Ozonoff A
    Hosp Pediatr; 2018 May; 8(5):293-299. PubMed ID: 29700011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding physicians' behavior toward alerts about nephrotoxic medications in outpatients: a cross-sectional analysis.
    Cho I; Slight SP; Nanji KC; Seger DL; Maniam N; Dykes PC; Bates DW
    BMC Nephrol; 2014 Dec; 15():200. PubMed ID: 25511564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determining Inappropriate Medication Alerts from "Inaccurate Warning" Overrides in the Intensive Care Unit.
    Rehr CA; Wong A; Seger DL; Bates DW
    Appl Clin Inform; 2018 Apr; 9(2):268-274. PubMed ID: 29695013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Evaluation of Drug-Drug Interaction Alerts Produced by Clinical Decision Support Systems in a Tertiary Hospital.
    Alanazi A; Alalawi W; Aldosari B
    Cureus; 2023 Aug; 15(8):e43141. PubMed ID: 37692642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cross-sectional observational study of high override rates of drug allergy alerts in inpatient and outpatient settings, and opportunities for improvement.
    Slight SP; Beeler PE; Seger DL; Amato MG; Her QL; Swerdloff M; Dalleur O; Nanji KC; Cho I; Maniam N; Eguale T; Fiskio JM; Dykes PC; Bates DW
    BMJ Qual Saf; 2017 Mar; 26(3):217-225. PubMed ID: 26993641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reasons provided by prescribers when overriding drug-drug interaction alerts.
    Grizzle AJ; Mahmood MH; Ko Y; Murphy JE; Armstrong EP; Skrepnek GH; Jones WN; Schepers GP; Nichol WP; Houranieh A; Dare DC; Hoey CT; Malone DC
    Am J Manag Care; 2007 Oct; 13(10):573-8. PubMed ID: 17927462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The frequency of inappropriate nonformulary medication alert overrides in the inpatient setting.
    Her QL; Amato MG; Seger DL; Beeler PE; Slight SP; Dalleur O; Dykes PC; Gilmore JF; Fanikos J; Fiskio JM; Bates DW
    J Am Med Inform Assoc; 2016 Sep; 23(5):924-33. PubMed ID: 27002076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wide variation and patterns of physicians' responses to drug-drug interaction alerts.
    Cho I; Lee Y; Lee JH; Bates DW
    Int J Qual Health Care; 2019 Mar; 31(2):89-95. PubMed ID: 29741633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective descriptive assessment of clinical decision support medication-related alerts in two Saudi Arabian hospitals.
    Alsaidan JA; Portlock J; Ata SI; Aljadhey HS; Franklin BD
    BMC Med Inform Decis Mak; 2022 Apr; 22(1):101. PubMed ID: 35428282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences among admitting departments in alerts and alert overrides for drug-drug interaction.
    Ahn EK; Kam HJ; Park DK; Jung EY; Lee Y; Park RW
    Pharmacoepidemiol Drug Saf; 2014 Apr; 23(4):390-7. PubMed ID: 24677664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug safety alert generation and overriding in a large Dutch university medical centre.
    van der Sijs H; Mulder A; van Gelder T; Aarts J; Berg M; Vulto A
    Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):941-7. PubMed ID: 19579216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structured override reasons for drug-drug interaction alerts in electronic health records.
    Wright A; McEvoy DS; Aaron S; McCoy AB; Amato MG; Kim H; Ai A; Cimino JJ; Desai BR; El-Kareh R; Galanter W; Longhurst CA; Malhotra S; Radecki RP; Samal L; Schreiber R; Shelov E; Sirajuddin AM; Sittig DF
    J Am Med Inform Assoc; 2019 Oct; 26(10):934-942. PubMed ID: 31329891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Turning off frequently overridden drug alerts: limited opportunities for doing it safely.
    van der Sijs H; Aarts J; van Gelder T; Berg M; Vulto A
    J Am Med Inform Assoc; 2008; 15(4):439-48. PubMed ID: 18436915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.